AG
CME icon

Ascent Group’s CME Group CME Stock Holding History

Ascent Group’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.46M Buy
15,087
+1,196
+9% +$355K 0.15% 133
2025
Q4 		$3.79M Buy
13,891
+1,037
+8% +$282K 0.13% 152
2025
Q3 		$3.47M Sell
12,854
-9,559
-43% -$2.6M 0.12% 162
2025
Q2 		$6.18M Buy
22,413
+580
+3% +$158K 0.24% 88
2025
Q1 		$5.79M Buy
21,833
+4,864
+29% +$1.2M 0.25% 85
2024
Q4 		$3.94M Buy
16,969
+3,147
+23% +$724K 0.3% 85
2024
Q3 		$3.05M Buy
13,822
+6,202
+81% +$1.28M 0.23% 104
2024
Q2 		$1.5M Sell
7,620
-457
-6% -$94.4K 0.12% 219
2024
Q1 		$1.74M Sell
8,077
-1,726
-18% -$363K 0.15% 203
2023
Q4 		$2.03M Buy
9,803
+532
+6% +$114K 0.19% 150
2023
Q3 		$2.01M Buy
9,271
+1,302
+16% +$259K 0.22% 134
2023
Q2 		$1.63M Sell
7,969
-768
-9% -$142K 0.18% 170
2023
Q1 		$1.67M Sell
8,737
-5,608
-39% -$1.01M 0.18% 168
2022
Q4 		$2.41M Buy
14,345
+62
+0.4% +$10.8K 0.28% 98
2022
Q3 		$2.48M Sell
14,283
-390
-3% -$77.1K 0.3% 92
2022
Q2 		$2.93M Buy
14,673
+982
+7% +$208K 0.35% 81
2022
Q1 		$3.26M Buy
13,691
+57
+0.4% +$13.4K 0.38% 82
2021
Q4 		$3.08M Buy
+13,634
New +$3M 0.39% 84

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ascent Group's CME Position: Q1 2026 in Review

Ascent Group increased its CME Group (CME) stake by 8.6% in Q1 2026, buying an estimated $355K and bringing the position to 15,087 shares worth $4.46M. The position accounts for 0.15% of the portfolio, ranked #133.

Ascent Group first reported a position in CME in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.18M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Ascent Group held 15,087 shares of CME Group worth $4.46M as of Q1 2026.
  • Ascent Group bought 1,196 CME Group shares in Q1 2026, an estimated $355K.
  • CME Group made up 0.15% of Ascent Group's portfolio in Q1 2026, its #133 holding.
  • Ascent Group first reported a position in CME Group in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's CME Group position peaked at $6.18M in Q2 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.